Cadila Pharma launches esomeprazole tablets in India
It will be marketed under brand name Esiloc in India for treatment of hyperacidity and drug induced gastritis
Ahmedabad-based Cadila Pharmaceuticals has announced the launch of esomeprazole tablets for the treatment of hyperacidity and drug-induced gastritis under the brand name Esiloc.
“Esiloc will be 50 per cent more economical, thus making it a superior yet affordable choice. It will be made available in 20 mg and 40 mg tablets,” informed the company through a statement.
Esomeprazole, a proton pump inhibitor (PPI), acts on the luminal surface of gastric parietal cells, resulting in inhibition of acid secretion. Esomeprazole provides higher rates of healing of erosive gastro-oesophageal reflux (GERD) and sustained resolution of heartburn in patients.
GERD, if untreated, can lead to conditions like peptic ulcer, chest pain, oesophagus cancer and other fatal conditions.